Diamond Pharma Services is a leading technical and scientific consulting group serving the biotechnology and pharmaceutical industry with a Global HQ in the UK and EU HQ in The Netherlands. Our emphasis is on the following areas: • Regulatory Affairs: From Product Concept to Registration and Beyond • Product Development: Nonclinical, CMC and Clinical Aspects • Pharmacovigilance: Clinical trial (Phase I-IV), Post-Marketing and QPPV Services • Compliance: GLP, GMP, GCP and QP Services • Patient Information Leaflet Testing: Over 120 Tested with 100% Positive Agency Feedback Our clients range from virtual start-up companies to the largest multi-national corporations. Our expertise includes products of recombinant DNA and hybridoma technology, nucleotide based products (RNA and DNA), synthetic peptides, chemical entities (innovative and generic), vaccines (therapeutic and prophylactic), blood products and advanced therapy medicinal products (gene therapy products). We have sophisticated and well-equipped office facilities and a state-of-the-art IT system. Our IT system includes a fully validated in-house eCTD system (Extedo) and safety database (ARISg). The company was founded in 2005 by Dr. Maureen Graham, formerly Director of Regulatory Affairs at Amgen. Our specialised team of more than 50 professionals includes those with a broad and varied industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit.